Trastuzumab Biosimilar - Research Grade: HRP

Trastuzumab Biosimilar - Research Grade: HRP, Host: Humanized, IgG1 kappa

Target: HER2.

Specificity: Detects human ErbB2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Trastuzumab.

Background: Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).

Concentration: 0.5mg/ml.

Formulation: This HRP-conjugated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4, 1% BSA. (Warning: Use of sodium azide as a preservative will inhibit the enzyme activity of horseradish peroxidase).

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH4013HRP-100UG
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH4013HRP-100UG
• Package Unit: 100μg
• Quantity Unit: STK
• Reactivity: Human
• Application: ELISA, Flow Cytometry
• Isotype: IgG1 kappa
• Host: Human